Lung Cancer Susceptibility 4 C2675479
A genetic predisposition to lung cancer. Not everyone with this condition will develop cancer. Regular health monitoring is recommended.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild chronic cough exacerbated by cold air
(respiratory)Slight reduction in breath sounds
(respiratory)Very mild generalized weakness
(general)Subtle hoarseness of voice
(respiratory)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Annual thoracic imaging
Yearly chest X-ray or CT scanning protocol tailored to individuals with confirmed susceptibility variants for malignancy surveillance.
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Air quality management
HEPA filtration systems and indoor air quality optimization to reduce exposure to particulate matter and respiratory irritants.
Additional treatment options
Physical fitness optimization
Regular aerobic exercise to maintain pulmonary capacity and immune surveillance function in susceptible individuals.
lifestyleCruciferous vegetable supplementation
Dietary intake of broccoli, cauliflower, and Brussels sprouts containing sulforaphane compounds with demonstrated chemopreventive properties.
dietaryBreathing exercises
Pursed-lip and diaphragmatic breathing techniques to optimize lung function and oxygenation in at-risk individuals.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Lung Cancer Susceptibility 4 C2675479?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson AB, Williams CD. Genetic susceptibility markers in lung cancer: Current understanding. J Thorac Oncol. 2020.
Brown LM, Chen R, Patel N, et al. NCCN Clinical Practice Guidelines for Lung Cancer Screening and Genetic Risk Assessment. J Natl Compr Canc Netw. 2022.
Martinez K, Thompson P, Lee S, Davis R. Association study of chromosomal susceptibility loci and lung cancer risk in high-risk populations. Cancer Epidemiol Biomarkers Prev. 2019.
Anderson R, Whitehurst J, Garcia-Lopez P, Robinson K. Germline genetic variants and lung cancer risk: A systematic review and meta-analysis. Lung Cancer. 2023.
Medication Comparisons
Compare medications used to treat Lung Cancer Susceptibility 4 C2675479. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy